Mayne Pharma Group Ltd MYX-AU:ASX

*Data is delayed | Exchange | AUD
Last | 4:10 PM AET
7.10quote price arrow down-0.02 (-0.28%)
Volume
73,461
52 week range
2.75 - 7.40
Loading...
  • Open7.00
  • Day High7.11
  • Day Low7.00
  • Prev Close7.12
  • 52 Week High7.40
  • 52 Week High Date04/08/24
  • 52 Week Low2.75
  • 52 Week Low Date10/17/23

Key Stats

  • Market Cap347.08M
  • Shares Out81.25M
  • 10 Day Average Volume165,845.2
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change15.45

KEY STATS

  • Open7.00
  • Day High7.11
  • Day Low7.00
  • Prev Close7.12
  • 52 Week High7.40
  • 52 Week High Date04/08/24
  • 52 Week Low2.75
  • 52 Week Low Date10/17/23
  • Market Cap347.08M
  • Shares Out81.25M
  • 10 Day Average Volume165,845.2
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change15.45

RATIOS/PROFITABILITY

  • EPS (TTM)-2.55
  • P/E (TTM)-2.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mayne Pharma Group Ltd

 

Content From Our Affiliates

Profile

MORE
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing generic pharmaceuticals. The Company operates through three segments: International, Branded Products Division (BPD) and Portfolio Products Division (PPD). Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. The...
Frank Condella Jr.
Non-Executive Independent Chairman of the Board
Shawn O' Brien
Chief Executive Officer, Managing Director, Executive Director
Aaron Gray
Chief Financial Officer
Address
1538 Main North Rd
Adelaide, SA
5106
Australia